pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
BTX-9341
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
BioTheryX Inc
0 catalysts
Phase 2
BTXA-51
Refractory Acute Myeloid Leukemia
Edgewood Oncology Inc
0 catalysts
BUDESONIDE INHALATION
BUDESONIDE INHALATION (BUDESONIDE INHALATION)
LUPIN
0 catalysts
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE)
HOSPIRA
← prev
page 65 of 231
next →
131
Pain89
Neurology1
0 catalysts
BUPRENORPHINE AND NALOXONE
BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)
MYLAN TECHNOLOGIES
0 catalysts
BUPRENORPHINE HCL
BUPRENORPHINE HCL (BUPRENORPHINE HCL)
SpecGx LLC
0 catalysts
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE)
SpecGx LLC
0 catalysts
BUTALBITAL AND ACETAMINOPHEN
BUTALBITAL AND ACETAMINOPHEN (BUTALBITAL AND ACETAMINOPHEN)
NE RX PHARMA
0 catalysts
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE)
GRANULES
0 catalysts
BUTALBITAL, ASPIRIN, AND CAFFEINE
BUTALBITAL, ASPIRIN, AND CAFFEINE (BUTALBITAL, ASPIRIN, AND CAFFEINE)
MPP PHARMA
0 catalysts
Preclinical
BVA-101
latrepirdine dihydrochloride
Multiple Sclerosis
Biovista Inc
0 catalysts
Preclinical
BVA-202
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
Biovista Inc
0 catalysts
Preclinical
BVA-203
Friedreich Ataxia
Biovista Inc
0 catalysts
Preclinical
BVA-501
Glioblastoma Multiforme (GBM)
Biovista Inc
0 catalysts
Preclinical
BVA-701
Glioblastoma Multiforme (GBM)
Biovista Inc
0 catalysts
Preclinical
BVX-001
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Bivictrix Therapeutics Ltd
0 catalysts
Phase 2
BW-00112
Mixed Dyslipidemia
Shanghai Argo Pharmaceutical Co Ltd
0 catalysts
Preclinical
BWV-302
Malaria
$ONCOOnconetix, Inc.
0 catalysts
Preclinical
BX-011
Diabetic Foot Infection (DFI)
$PHGEBiomX Inc.
0 catalysts
Phase 2
BX-1000
Anesthetic Effect
Baudax Bio Inc
0 catalysts
Phase 2
BX-211
Diabetic Foot Infection (DFI)
$PHGEBiomX Inc.
0 catalysts
Phase 2
BXQ-350
Metastatic Colorectal Cancer
Bexion Pharmaceuticals Inc
0 catalysts
Preclinical
BY-103
Blood Cancer
BoYen Therapeutics Inc
0 catalysts
Phase 1
Bapotulimab
Head And Neck Squamous Cell Carcinoma (HNSC)
Bayer AG
0 catalysts
Phase 2
Base-Edited Hematopoietic Stem and Progenitor Cells
Chronic Granulomatous Disease
The National Institute of Allergy and Infectious Diseases
0 catalysts
Preclinical
Batten CLN1 Inhibitor
Batten Disease
Collaborations Pharmaceuticals Inc
0 catalysts
Marketed
Betimol
Betimol (timolol maleate)
Ocular Hypertension
Thea Pharma Inc
0 catalysts
Preclinical
Bi-104
Angelman Syndrome
Biom Therapeutics LLC
0 catalysts
Marketed
Bicillin L A
Bicillin L A (penicillin G benzathine)
Upper Respiratory Tract Infections by Streptococcus pyogenes
$PFEPFIZER INC
0 catalysts
Phase 1
Biostage Esophageal Implant
Esophageal Cancer
$HRGNHarvard Apparatus Regenerative Technology, Inc.
0 catalysts